By continuing to use the site you agree to our Privacy & Cookies policy

NICE puts onus on pharma giant after rejecting 'costly' breast cancer drug

The National Institute for Health and Care Excellence has taken the unprecedented step of expressing its “disappointment” with a multinational drug giant in a row over a new breast cancer drug and government’s pricing deal with the pharmaceutical industry.

Continue reading - simply register below

It only takes two minutes to do and you'll immediately have access to our news and opinion articles and you'll be able to sign up for our newsletters.

Already registered?

To check that you are registered please enter your email address below

Our records show you are already a registered user. Please sign-in with your password.

By continuing to use the site you agree to our Privacy & Cookies policy

Not registered?

Registration is free and takes just two minutes. After you register, you'll get access to our news and opinion stories and you'll be able to sign up to our newsletters.

newsletterpromo